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and practice, infection control rate will be promoted using
related educational programs.
doi:10.1016/j.ijid.2008.05.422
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The Linear Behaviour of Pathogen Strain of Bacillus
anthracis A0843 in Anthrax Subcutaneous Challenge on
Rabbit Model
A. Fasanella1,∗, R. Adone2, S. Losito1, D. Chiocco1, G.
Garofolo1, S. Scasciamacchia1
1 Anthrax Reference Institute of Italy, Foggia, Italy
2 Istituto Superiore di Sanita`, Rome, Italy
Background: The pathogen strain of Bacillus anthracis
A0843, isolated during an anthrax outbreak occurred in Italy,
belongs to the Cluster A1a genotype 3. The authors show its
activity underlining that the regular behaviour could make
it useful as a reference strain for subcutaneous challenge in
rabbit model for anthrax vaccines efﬁcacy test. Italy doesn’t
use Ames strain because the restrictive measures, imposed
after the bioterroristic events occurred in October 2001 in
USA, reduced the movements of pathogen agents between
reference laboratories in the world. It is necessary to adopt
new rules that favour the security and the regularity of the
research.
Method: This study was done, during 3 years, on 50 New
Zeeland rabbits, males and females, with a weigh between
1.200 and 1500 grams. The site of injection was back in
the space between the two scapulae. It was used 20 LD50
(about 40.000 spores) of the pathogen strain according to
the European Pharmacopoeia.
Results: It was observed that anthrax begins to kills after
48 hours from the infection. At 72 hours the percentage of
survival is 56,66%; at 96 hours is 30%. It was observed that
two animals that survived after 120 hours from infection
didn’t die.
Conclusion: The LD50 of B. anthracis strain A0843 in rab-
bit is 2.000 spores, less virulent then Ames strain which is
characterized of a LD50 of about 1.200 spores. The standard
amount of 20 DL50 (about 40.000 spores) of B. anthracis
strain A0843 injected in subcutaneous area in rabbits shows
a linear behaviour. The higher mortality is observed between
72 and 96 hours. All the animals died within 120 hours from
the infection. None of the infected animals survived over
this time and we consider it the survival line of anthrax
subcutaneous challenge in rabbit.
Technical support: Angela Aceti and Nicola Nigro
Founds: Ricerca Corrente 2005 of Ministry of Health of
Italy
This research was done in according to the Decreto leg-
islativo n.116/92 on animal welfare
doi:10.1016/j.ijid.2008.05.423
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Background: Aﬂatoxins are well-known secondary
metabolites of the mould Aspergillus ﬂavus, but it is not
clear whether aﬂatoxins are produced in tissues in the
course of invasive aspergillosis due to aﬂatoxinogenic
Aspergillus ﬂavus strains. We sought to determine whether
aﬂatoxin B1 is produced in tissues in experimental invasive
aspergillosis due to aﬂatoxinogenic Aspergillus ﬂavus.
Methods: Corticosteroid-treated (immunosuppressed)
Wistar rats received intravenous challenge with conidia from
a known aﬂatoxin B1-producing strain of Aspergillus ﬂavus
(test rats) or with conidia from a aﬂatoxin non-producing
strain of Aspergillus ﬂavus (control rats). Animals were sac-
riﬁced after 10 days and key organs dissected out. Thin-layer
chromatography was used to detect aﬂatoxin B1 in tissue
homogenates; in addition, total protein concentration and
protein proﬁles were determined. Histopathological studies
were also done.
Results: Aﬂatoxin B1 was detected in concentrations of
120 ppb and 70 ppb, respectively, in homogenates of liver
and kidney of test rats, but was not detected in tissue
homogenates from control rats. The total protein concen-
tration as well as the protein proﬁles of homogenates of the
liver, kidneys, eyes and spleen of test rats tended to show
much greater alterations than those in control rats. Invasion
of tissue by fungal hyphae tended to be more intense in test
than in control rats, while the histoarchitecture of liver, kid-
ney and spleen tissues underwent greater disruption in test
than in control rats.
Conclusions: Aﬂatoxin B1 is produced in tissues in
experimental invasive aspergillosis due to aﬂatoxinogenic
Aspergillus ﬂavus and may account for the pronounced
alterations in protein proﬁles and histoarchitecture com-
pared to that occurring in invasive aspergillosis due to
aﬂatoxin non-producing Aspergillus ﬂavus.
doi:10.1016/j.ijid.2008.05.424
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Background: T-705, an oral anti-inﬂuenza virus agent dis-
covered by Toyama Chemical. Co., Ltd., and is currently
under clinical development. T-705 exhibits in vitro and in
vivo antiviral effect against inﬂuenza A and B. Further-
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more, anti-A/H5N1 virus activity of T-705 was reported
(R. W. Sidwell of Utah State University. In this study, we
focused on the relevance of pharmacokinetic (PK) param-
eters to virologic response in an inﬂuenza infection mouse
model.
Method: Mice were inoculated intranasally with mouse-
adapted inﬂuenza virus strain type of A/H3N2. Antiviral
effect of T-705 was determined by the pulmonary viral load
at the end of T-705 treatment period in dose regimen indi-
cated in the Table. T-705 was administered orally for 5 days
starting at 1 hour post infection. Cmax and Ctrough, AUC from 0
to 24 hours and Time maintaining the concentrations above
IC50 and 10 times the IC50 in steady state were calculated
from PK parameters following single shot of T-705 in unin-
fected normal mice. Correlation between each parameter
and lung virus titer was analyzed using Peason’s correlation
coefﬁcient test.
Result: The PK parameters that most closely correlated
with pulmonary viral load reduction was AUC among esti-
mated PK parameters of T-705.
Conclusion: The PK parameter that most closely cor-
related with in vivo antiviral efﬁcacy was AUC in the
present study. Further studies are required to determine
the effect of time dependency on antiviral efﬁcacy with
an analysis dependent on another regimen of T-705 treat-
ment.
doi:10.1016/j.ijid.2008.05.425
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Study of Sedative and Anxiolytic Effects of Herbal Extract
Hypericum perforatum in Comparison with Diazepam in
Rats
A. Rezaie ∗, K. Rezaee Dorostkar, M. Pashazadeh, S. Moham-
mad Nejad
Islamic Azad, Tabriz, Iran (Islamic Republic of)
Keywords: Hypericum perforatum; Elevated plus Maze;
Diazepam; Ketamin
Hypericum perforatum or St. John’s wort is a plant
known Raee ﬂower in Persian hyperisin and hyperforin are
main constituents of this plant extract. Latter studies in
laboratory ﬁeld are indicating inhibition of MAO by com-
pounds present at Raee ﬂower extract. Hyperforin present
at this plant results in inhibitory reuptake of serotonin,
dopamine, norepinephrine. The extract constituents of this
plant, also,connect to sigma Opioid and GABA receptors. The
aim of this study is to assess sedative and anxiolytic effects
of Raee extract in comparison with diazepam in rat pattern.
To this end, the hydro alcohol extract of plant aerial organ
was provided. Then doses 500mg/kg and 250mg/kg of of
extract, 1/2mg/kg of diazepam and also di-metyl solphoxid
with equal volume was injected into peritoneum of differ-
ent groups of female rats in Vistar race with equal age and
weight conditions, (as plasebo), 15min before assessing the
sedative/sleep inducing effects (induced sleep duration by
Ketamin, dose 44mg/kg) and anxiolytic effects (using Ele-
vated plus Maze). The results showed meaningful increase in
induced sleep duration by Ketamin and time duration passed
in 0pen arms (branches) at patients groups having high and
low doses of extract. (p < 0,01). Obtained results indicated
that extract of Raee ﬂower gives sedative and anxiolytic
effects.
doi:10.1016/j.ijid.2008.05.426
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Primary Vaccination with a Diphtheria, Tetanus, Acellular
Pertussis, Haemophilus Inﬂuenzae Type B Conjugate Vac-
cine (Pentaxim) at 6, 10 and 14 Weeks of Age of Infants
in South Africa
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Background: There are few data on the immunogenicity
and safety of acellular pertussis-based combination vaccines
when given in the recommended WHO EPI schedule at 6, 10
and 14 weeks of age.
Methods: A series of 212 infants in South Africa were
sequentially enrolled, to receive a pentavalent combination
vaccine containing diphtheria, tetanus, acellular pertussis,
inactivated poliovirus, Haemophilus inﬂuenzae type b con-
jugate (PRP-T) antigens (PentaximTM, Sanoﬁ Pasteur, AcXim
family vaccine) concomitantly with a monovalent hepatitis
B vaccine (Heberbiovac HBTM) at 6, 10 and 14 weeks of age.
Antibody titers were measured immediately before and one
month after the three-dose primary vaccination. Immuno-
genicity results obtained in French children vaccinated at 2,
3, 4 months of age, were used as a reference. Reactogenicity
and safety were evaluated from parent reports.
Results: After three doses of vaccine, the anti-PRP GMT
was 2.01g/mL, anti-polio GMTs were 1453, 1699, and
2398 (1/dil U) for types 1, 2, and 3, respectively. Anti-
PT and ant-FHA GMTs increased pre- to post-vaccination
from 7.0 to 383 EU/mL, and from 9.6 to 161 EU/mL, respec-
tively and all subjects had anti- PT and -FHA antibody titers
≥25 EU/mL. Two-fold increase in antibody concentration
pre- to post-vaccination was 99.0% and 94.6%, for PT and
FHA respectively. Anti-HBs GMT was 929mIU/mL and all chil-
dren had anti-HBs ≥10mIU/mL. Vaccine reactogenicity was
low, most reactions being mild or moderate, and there were
no drop outs due to adverse events. Rates of severe solicited
local adverse reactions (pain, redness and swelling) were
≤0.6%, and severe systemic solicited adverse events were
from 0.5 to 1.3%, after any given dose of either vaccine. No
hypotonic hyporesponsive episodes were reported.
Conclusion: The immunogenicity of Pentaxim given at 6,
10 and 14 weeks of age was high in South African infants,
similar to the ﬁndings of an earlier French trial, and a trial in
children in the Philippines using same 6, 10, 14 wk EPI sched-
ule.(1) Concurrent Hepatitis B vaccine produced a strong
immune response. The combined vaccine and the hepatitis
B vaccine were both well tolerated. [NCT 00254969].
(1) Capeding MR, Cadorna-Carlos J, Book-Montellano M,
Ortiz E. Immunogenicity and safety of a DTaP-IPV//PRP∼T
combination vaccine at 6, 10, 14 weeks of age (EPI schedule)
and concomitant Hepatitis B vaccination at birth, 6, 14 or 6,
10, 14 weeks of age. Bull World Health Org 2008; in Press
doi:10.1016/j.ijid.2008.05.427
